Monthly Multi-Institutional Hematopathology Interesting Case Conference

 

The Multi-Institutional Hematopathology Interesting Case Conference (MHICC) is a monthly virtual CME meeting to provide a platform for oncologists, pathologists, and trainees from leading institutions across North America to collaboratively discuss complex and educational hematopathology cases. This interactive and case-based discussion forum offers a unique opportunity to engage with experts, review complex cases, and strengthen interdisciplinary collaboration in hematopathology.

Schedule for 2025 MHICC

Date Presenting Institution
February 26 FCCC
March 19 Mount Sinai
May 28 Cleveland Clinic
June 25 Weill Cornell Medical College
August 27 University of Toronto
September 24 UPenn
October 22 NYU
November 26 Mass General Brigham
December 7 Emory University

Participating Institutions: Cleveland Clinic, Emory University, Fox Chase Cancer Center, Icahn School of Medicine at Mount Sinai, Mass General Brigham, Memorial Sloan Kettering Cancer Center, National Institutes of Health (NIH), NYU Grossman School of Medicine, University of Pennsylvania, University of Toronto, Weill Cornell Medicine

Upcoming Session

Date: Wednesday, August 27, 2025
Time: 5:00PM (EST)
Presenting Institution: University of Toronto

To Access the Meeting:

1. Click here
2. Sign-in with your EMAIL and click “Next”
3. Enter your personal information requested and click “Sign in Now
4 .Click “Watch this Lecture Remotely” to enter the meeting

Cases to be Discussed:
Case 1: A 49-year-old man with back pain and a lytic bone lesion in L1 vertebra.– Stains: 1- H&E, 2- CD20, 3- CD138. View Slides

Case 2: 73-year-old man with left inguinal lymphadenopathy,– Stains: 1 – H&E, 2- CD2, 3- CD20. View Slides

Case 3: 66-year-old man with right axillary lymph node enlargement – Stains: 1- H&E, 2- CD20, 3- CD3. View Slides

Case 4: 44-year-old man with cervical lymphadenopathy and history of treated DLBCL,– Stains: 1- H&E, 2- Lysozyme. View Slides


Educational Objectives:
By participating in this monthly conference, attendees will be able to:

  1. Discuss key concepts related to hematopathology including flow cytometry, broadly-defined molecular, cytogenetic and clinical findings as well as therapeutic implications.
  2. Identify and analyze challenging hematologic neoplasms, applying updated diagnostic criteria and emerging recommendations to improve patient outcome.
  3. Integrate novel diagnostic modalities and recent advancements in hematopathology to enhance diagnostic accuracy and facilitate more precise clinical decision-making.

Target Audience:
The MHICC is designed for a diverse audience of healthcare professionals with an interest in hematopathology and related fields. This includes, but is not limited to:

  • Pathologists, as well as Medical and Radiation Oncologists
  • Fellows, Residents, and Trainees in Pathology, Hematopathology, Molecular Pathology, Hematologic Oncology, and Radiation Oncology

For more information, please contact Reza Nejati, MD, Chair of the Organizing Committee, at Reza.Nejati@fccc.edu.

CME Information and Credit Instructions 

To Access your CME Certificate:
After the meeting, you’ll receive an email prompting you to complete a brief evaluation. Once submitted, your credit certificate will be available for download—please remember to save it for your records.

Accreditation Statement:
Temple Health is accredited by the Pennsylvania Medical Society to provide continuing medical education for physicians.

Credit Designation:
Temple Health designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the educational activity.

If you have any questions regarding CME credits, please don’t hesitate to reach out to Lucía Tono at Lucia.Tono-Ramirez@tuhs.temple.edu.

Previous Cases

Date: Wednesday, June 25, 2025

Presenting Institution: Weill Cornell Medical College

Case 1: A 3-year-old boy presenting with stridor and found to have a 0.5 cm mass in the subglottis. View Slides

Case 2: A 68-year-old female with a history of CLL/SLL who presents with worsening abdominal pain. PET-CT showed new FDG avid lymph nodes and multiple hepatic and splenic lesions.  View Slides

Case 3: A 61-year-old man with a history of bipolar disorder and alcohol abuse presents with declining mental status over the past month. MRI showed multiple intracerebral lesions. View Slides

 

Date: Wednesday, May 28, 2025

Presenting Institution: Cleveland Clinic

View Slides for Cases 1 - 4

Case 1: A 74-year-old male with history of squamous cell carcinoma of the tongue now presents with new tonsillar mass.

Case 2: A 65-year-old female with history of Inflammatory bowel disease on treatment presents with incidental finding of left adrenal cyst (16 cm) noted on imaging.

Case 3: An 82-year-old male with history of B-cell lymphoma from an outside hospital, now presenting with visible right neck lymphadenopathy and weight loss. Abbreviated ancillary studies provided for discussion around molecular findings.

Case 4: A 45-year-old male with an isolated enlarged left groin lymph node. View Slides

 

Date: Wednesday, April 23, 2025

Presenting Institution: MSKCC

Case 1: A 66F w/ history of breast carcinoma status post adjuvant chemotherapy and radiotherapy, presenting with neutropenia (ANC 0.7 K/uL), mild anemia (Hb 10.9 g/dL, MCV 95 fL, RDW 14%), and mild thrombocytopenia (Platelets 126 K/uL). View Slides

Case 2: A 58F w/ a history of a myeloid neoplasm favored to be oligomonocytic chronic myelomonocytic leukemia presents with widespread lymphadenopathy. View Slides

Case 3: A 63F with a history of breast carcinoma status post cytotoxic therapy presents with widespread lytic bone lesions, marked anemia (Hb 6.9 g/dL, MCV 98fL, RDW 22.1%) and thrombocytopenia (Platelets 64 K/uL). View Slides

 

Date: February 26, 2025

Presenting Institution: FCCC

Case 1: A 70-year-old man with a history of chronic lymphocytic leukemia (CLL) with unexplained neutrophilia. View Slides

Case 2: A 68-year-old man with violaceous-pink raised skin lesions. View Slides

Case 3: A 65-year-old man with a history of multiple myeloma with worsening leukocytosis. View Slides

Case 4: A 56-year-old woman with a history of AML with inversion 16 now with pancytopenia including severe neutropenia at ~220 days post-transplant. View Slides

 

Date: Wednesday, March 19, 2025

Presenting Institution: Mount Sinai

Case 1: A 70-year-old man with a history of chronic lymphocytic leukemia (CLL) with

unexplained neutrophilia. View Slides

Case 2: A 68-year-old man with violaceous-pink raised skin lesions. View Slides

Case 3: A 65-year-old man with a history of multiple myeloma with worsening leukocytosis. View Slides

Case 4: A 56-year-old woman with a history of AML with inversion 16 now with pancytopenia including severe neutropenia at ~220 days post-transplant. View Slides


Published

February 24, 2025

Expires

February 24, 2026